Esperion Therapeutics Inc
LSE:0IIM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Esperion Therapeutics Inc
LSE:0IIM
|
US |
|
B
|
BankUnited Inc
F:BNU
|
US |
Wall St Price Targets
0IIM Price Targets Summary
Esperion Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 0IIM is 2.9755 USD with a low forecast of 1.8036 USD and a high forecast of 3.4549 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0IIM's stock price target?
Price Target
2.9755
USD
According to Wall Street analysts, the average 1-year price target for 0IIM is 2.9755 USD with a low forecast of 1.8036 USD and a high forecast of 3.4549 USD.
What is the Revenue forecast for Esperion Therapeutics Inc?
Projected CAGR
3%
The compound annual growth rate for Revenue over the next 8 years is 3%.
What is the Gross Profit forecast for Esperion Therapeutics Inc?
Projected CAGR
29%
The compound annual growth rate for Gross Profit over the next 5 years is 29%.
What is the Operating Income forecast for Esperion Therapeutics Inc?
Projected CAGR
28%
The compound annual growth rate for Operating Income over the next 8 years is 28%.
